Aprea Therapeutics Inc
Biotechnology
Healthcare
APRE
5.99 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.47
52 week high
4.45
high
1.47
52 week low
0.00
low
1.40
growth
-53.99 %
previous Close
1.47
P/E ratio
market cap
9.40 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
19.22 %
eps surprise
25.35 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top